Mouse and man: Multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders

Journal of Autoimmunity

Volumn 9, Issue 2, 1996, Pages 277-281

  Gottlieb, Peter A ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibodies; GAD; Genetics; IDM; Immunology; NOD mice; T cell receptor

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CONFERENCE PAPER; ETIOLOGY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030002227     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0035     Document Type: Conference Paper

References (40)

1. Eisenbarth G.S. 1986. Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
2. Hattori M., Buse J.B., Jackson R.A., Glimcher L., Makino S., Moriwaki K., Korff M., Minami M., Kuzuya H., Imura H., Seidman J.G., Eisenbarth G.S. 1986. The NOD mouse: recessive diabetogenic gene within the major histocompatibility complex. Science 231: 733-735
3. Slattery R.M., Kjer-Nielsen L., Allison J., Charlton B., Mandell T.E., Miller J.F.A.P. 1990. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 345: 724-726
4. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. 1987. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328: 432-434
5. Baisch J.M., Weeks T., Giles R., Hoover M., Stastny P., Capra J.D. 1990. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 322: 1836-1841
6. Huang W., She J., Muir A., Laskowsa D., Zorovich B., Schatz D., Maclaren N. 1994. High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent them. J. Autoimmunity 7: 889-897
7. Pugliese A., Moromisato R., Awdeh Z.L., Alper C.A., Erlich H.A., Jackson R.A., Eisenbarth G.S. 1995. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes. Diabetes 44: 608-613
8. Auwera B., Schuit F., Lyaruu I., Falorni A., Svanholm S., Vandewalle C., Gorus F., Belgian Diabetes Registry. 1995. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. J. Clin. Endocrinol. Metab. 80: 2567-2573
9. Eisenbarth G.S., Rewers, M. 1995. Refining genetic analysis of type I diabetes. J. Clin. Endocrinol. Metab. (in press)
10. Ziegler A.G., Standl E., Albert E., Mehnert H. 1991. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes 40: 1146-1149
11. Verge C.F., Gianani R., Yu L., Pietroapolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. 1995. Prediction of type I diabetes in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512 autoantibodies (submitted)
12. Marsh M.N. 1992. Gluten, Major Histocompatibility Complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102: 330-354
13. Eisenbarth G.S., Jackson R.A. 1992. The immunoendocrinopathy syndromes. In Williams Textbook of Endocrinology. J.D. Wilson and D.W. Foster, eds. W.B. Saunders Company, Philadelphia. 1555-1566
14. Roep, B.O., DeVries R.R. 1992. T lymphocytes and the pathogenesis of type I (insulin dependent) diabetes mellitus. Eur. J. Clin. Invest. 22: 697-711
15. Durinovic-Bello I., Steinle A., Ziegler A.G., Schendel D.J. 1994. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 43: 1318-1325
16. Owerbach D., Gabbay K.H. 1993. Localization of a type 1 diabetes susceptibility locus to the variable tandem repeat region flanking the insulin gene. Diabetes 42: 1708-1714
17. Bennett S.T., Lucassen A.M., Gough S.C.L., Powell E.E., Undlien D.E., Pritchard L.E., Merriman M.E., Kawaguchi Y., Dronsfield M.J., Pociot F., Nerup J., Bouzekri N., Cambon-Thomsen A., Ronningen K.S., Barnett A.H., Bain S.C., Todd J.A. 1995. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet. 9: 284-292
18. Kennedy G.C., German M.S., Rutter W.J. 1995. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nature Genet. 9: 293
19. Jolicoeur C., Hanahan D., Smith K.M. 1994. T-cell tolerance toward a transgenic B-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl. Acad. Sci. USA 91: 6707-6711
20. Prochazka M., Serreze D.V., Frankel W.N., Leiter E.H. 1992. NOR/Lt Mice: MHC-matched Diabetes Resistant Control Strain for NOD Mice. Diabetes 41: 98-106
21. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., Reed P.W., Gough S.C.L., Jenkins S.C., Palmer S.M., Balfour K.M., Rowe B.R., Farrall M., Barnett A.H., Bain S.C., Todd J.A. 1994. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371: 130-136
22. Eisenbarth G.S., Gianani R., Yu L., Pietropaolo M., Verge C.F., Falorni A., Chase H.P., Rabin D.U., Lernmark A., Jackson R. 1995. Unique correlation of anti-insulin autoantibodies with age of diabetes onset and rate of progression to type I diabetes (submitted)
23. Wegmann D., Norbury-Glaser M., Daniel D. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24: 1853-1857
24. Daniel D., Gill R.G., Schloot N., Wegmann D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062
25. Lipes M.A., Rosenzweig A., Tan K.N., Tanigawa G., Ladd D., Seidman J.G., Eisenbarth G.S. 1993. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science 259: 1165-1169
26. Schloot N., Daniel D., Wegmann D. 1994. Limiting dilution analysis of islet infiltrating and peripheral T cells in prediabetic mice. Diabetologia 37: 364 (Abstract)
27. Atkinson M., Maclaren N., Luchetta R., Burr I. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933-937
28. Zhang J.Z., Davidson L., Eisenbarth G.S., Weiner H.L. 1991. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252-10256
29. Muir A., Peck A., Clare-Salzler M., Yao-Hua S., Cornelius J., Luchetta R., Krischer J., Maclaren N. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95: 628-634
30. Keller R.J., Eisenbarth G.S., Jackson R.A. 1993. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet 341: 927-928
31. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. 1990. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
32. Grubin C.E., Daniels R., Toivola B., Landin-Olsson M., Hagopian A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A. 1994. A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350
33. Harrison L.C., Honeyman M.C., De Aizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. 1993. Inverse relationship between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369
34. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72
35. Tisch R., Yang X., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75
36. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Ding-Fang B., Erlander M.G., Tobin A.J., Maclaren N.K. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459
37. Rabin D.U., Pleasic SM., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., Goldstein D.E., Rae P.M.M. 1994. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152: 3183-3187
38. Lan M.S., Lu J., Goto Y., Notkins A.L. 1994. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA and Cell Biology 13: 505-514
39. Elias D., Reshef T., Birk O.S., Zee R., Walker M.D., Cohen I.R. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091
40. Verge C.F., Gianani R., Yu L., Pietropaolo M., Smith T., Jackson R.A., Soeldner J.S., Eisenbarth G.S. 1995. Late progression to diabetes and evidence for chronic beta cell autoimmunity in identical twins of patients with type I diabetes. Diabetes 44: 1176-1179